METABOLOMIC DIAGNOSTICS LIMITED - Ireland 

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 1
Sole participant: 2
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 2.069.891 0 2.069.891 2
2012 0 5.995.390 499.616 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACCELOPMENT1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
KAROLINSKA INSTITUTE1
KLINIKUM DER UNIVERSITAET ZU KOELN1
MEDSCINET AB1
PRONOTA NV1
REGION HOVEDSTADEN1
RIJKSUNIVERSITEIT GRONINGEN1
THE UNIVERSITY OF LIVERPOOL1
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK1
UNIVERSITY OF KEELE1

Constancy:

Total number of partners: 11
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 11
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2018-11-01Improving Pregnancy Outcomes Gloablly IPOGcoordinator1.894.0251
2018-06-01PREeclampsia risk stratification test: development of a suitable CALIbration framework for the analysis of a multiplex panel of endogenous compounds by LC-MS PRECALIcoordinator175.8661
2012-11-01IMPROvED: IMproved Pregnancy Outcomes by Early Detection; personalized medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome IMPROVEDparticipant5.995.39012